Intraarticular injection of liposomal adenosine reduces cartilage damage in established murine and rat models of osteoarthritis

• Published in: Scientific reports Vol. 10; no. 1; p. 13477
• Main Authors: Corciulo, Carmen, Castro, Cristina M., Coughlin, Thomas, Jacob, Samson, Li, Zhu, Fenyö, David, Rifkin, Daniel B., Kennedy, Oran D., Cronstein, Bruce Neil
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 10-08-2020; Nature Publishing Group
• Subjects: 692/308/1426; 692/4023/1670/407; Adenosine; Adenosine - administration & dosage; Adenosine - analogs & derivatives; Adenosine - metabolism; Adenosine - pharmacology; Agonists; Animal models; Animals; Arthritis; Autocrine signalling; Cartilage; Cartilage - drug effects; Cartilage - metabolism; Cartilage diseases; Cartilage, Articular - drug effects; Cartilage, Articular - metabolism; Cell Differentiation; Cell proliferation; Chondrocytes; Chondrocytes - metabolism; Chondrogenesis; Disease Models, Animal; Gene expression; Homeostasis; Humanities and Social Sciences; Injection; Injections, Intra-Articular - methods; Knee; Liposomes; Liposomes - administration & dosage; Liposomes - metabolism; Liposomes - pharmacology; Male; Mice; Mice, Inbred C57BL; mRNA; multidisciplinary; Osteoarthritis; Osteoarthritis - drug therapy; Osteoarthritis - metabolism; Phenethylamines - pharmacology; Rats; Rats, Sprague-Dawley; Science; Science (multidisciplinary); Signal Transduction; Smad2 protein
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-68302-w

Osteoarthritis (OA) affects nearly 10% of the population of the United States and other industrialized countries and, at present, short of surgical joint replacement, there is no therapy available that can reverse the progression of the disease. Adenosine, acting at its A2A receptor (A2AR), is a critical autocrine factor for maintenance of cartilage homeostasis and here we report that injection of liposomal suspensions of either adenosine or a selective A2AR agonist, CGS21680, significantly reduced OA cartilage damage in a murine model of obesity-induced OA. The same treatment also improved swelling and preserved cartilage in the affected knees in a rat model of established post-traumatic OA (PTOA). Differential expression analysis of mRNA from chondrocytes harvested from knees of rats with PTOA treated with liposomal A2AR agonist revealed downregulation of genes associated with matrix degradation and upregulation of genes associated with cell proliferation as compared to liposomes alone. Studies in vitro and in affected joints demonstrated that A2AR ligation increased the nuclear P-SMAD2/3/P-SMAD1/5/8 ratio, a change associated with repression of terminal chondrocyte differentiation. These results strongly suggest that targeting the A2AR is an effective approach to treat OA.